Video Reports

Embed this video

Copy Code

Link to this video

Get LinkEmbedLicenseRecommend (-)Print
Bookmark and Share

By Katie Rushkewicz Reichart, CFA | 05-01-2017 02:00 PM

A Solid, Reasonably Priced Core Holding

Bronze-rated T. Rowe Price Value has a diversified portfolio with a slight preference recently for healthcare and consumer-related stocks.

Securities mentioned in this video
TRVLX T. Rowe Price Value

Katie Reichart: T. Rowe Price Value receives a Morningstar Analyst Rating of Bronze. Mark Finn, previously an analyst, has run the fund since 2010. He's backed by a strong analyst team at T. Rowe that provides bottom-up stock ideas.

Finn uses a relative value approach, looking primarily for large-cap stocks that are reasonably valued relative to their histories, the market, or on a sum-of-the-parts basis. The resulting portfolio is diversified across 100 or more names, with a slight preference recently for healthcare and consumer-related stocks. The fund has edged the Russell 1000 Value Index during Finn's tenure and has outperformed 85% of its large value peers.

It won't be on top in every market environment; it lagged the benchmark and peers in 2016, a strong market for value, due to some poor stock picks and above-average healthcare exposure. But it's rebounded so far in 2017, and long-term it remains a solid and reasonably priced choice for the core part of an investor's portfolio.

{1}
{1}
{2}
{0}-{1} of {2} Comments
{0}-{1} of {2} Comment
{1}
{5}
  • This post has been reported.
  • Comment removed for violation of Terms of Use ({0})
    Please create a username to comment on this article
    Username:
    Content Partners